SCHEDULE 13D/A: Adagene CEO Peter Luo Updates Stake, Shifts Significant Holdings to Family Trust for Estate Planning

Adagene, Inc. CEO Peter Luo and related entities have updated their beneficial ownership, including significant transfers of shares to the HAN 2020 Irrevocable Trust for estate planning purposes and a change in the trust's independent trustee.

Summary

• Peter Luo and the HAN 2020 Irrevocable Trust have filed an Amendment No. 3 to Schedule 13D regarding their beneficial ownership in Adagene, Inc.
• As of January 25, 2025, Peter Luo beneficially owns 3,681,318 ordinary shares, representing 6.07% of the class.
• The HAN 2020 Irrevocable Trust beneficially owns 9,175,439 ordinary shares, representing 15.58% of the class.
• On May 6, 2024, Peter Luo received 1,108,333 ordinary shares and Xiaohong She received 234,167 ordinary shares from Great Han Fortune LP.
• Also on May 6, 2024, Peter Luo transferred 2,889,074 ordinary shares and Xiaohong She transferred 286,365 ordinary shares to the HAN 2020 Irrevocable Trust for estate planning.
• On December 19, 2024, the trustee of the HAN 2020 Irrevocable Trust was changed from Xiaohong She to North Point Trust Company, an independent trustee, which means beneficial ownership of the trust is no longer attributed to Peter Luo or Xiaohong She.
• Peter Luo remains subject to a Concert Party Agreement dated December 14, 2020, with the Peter Luo-Acting-in-Concert-Group, which dictates acting in concert on voting rights and recognizing Peter Luo's controlling position.
• Several members of the Concert Party Group (Dr. Hua Gong, Yu (Albert) Ren, Fangyong (Felix) Du, and Ping Ren) are no longer subject to the agreement due to their departure from Adagene.

Sentiment

Score: 7

Explanation: The filing indicates stable, long-term planning by the CEO through estate transfers and the appointment of an independent trustee, which are generally positive for corporate governance. The continued significant beneficial ownership by the CEO and related entities, despite the structural changes, suggests ongoing commitment. The departure of some concert party members is noted but attributed to their leaving the Issuer, not necessarily a negative for the company itself.

Positives

• The transfers to the HAN 2020 Irrevocable Trust indicate proactive estate planning by the CEO, which can be a sign of long-term commitment and stability.
• The appointment of an independent trustee (North Point Trust Company) for the HAN 2020 Irrevocable Trust enhances governance and transparency regarding the trust's holdings.

Negatives

• The shift of beneficial ownership of the HAN 2020 Irrevocable Trust away from Peter Luo and Xiaohong She, while for estate planning, means their direct attributed beneficial ownership percentage decreases, which could be perceived as a slight reduction in direct control, though Peter Luo remains CEO and Chairman.
• The departure of several key individuals from the "Peter Luo-Acting-in-Concert-Group" could indicate changes in the core leadership or strategic alignment, though the document states it's due to their departure from the Issuer.

Risks

• Changes in beneficial ownership and control structures, even for estate planning, can sometimes introduce uncertainty regarding future strategic direction or voting power dynamics.
• The Concert Party Agreement, while ensuring Peter Luo's control, also means his beneficial ownership can fluctuate based on the actions of other group members, potentially leading to deemed acquisitions or dispositions.

Future Outlook

The reporting persons, including Mr. Luo and members of the Peter Luo-Acting-in-Concert-Group, may acquire additional ordinary shares in the ordinary course of business, potentially through outstanding options, additional options granted by the Issuer, or a personal share repurchase plan established by Mr. Luo.

Management Comments

• "The Reporting Persons acquired the ordinary shares reported herein for investment and estate planning purposes, in the ordinary course of business."
• "Other than as disclosed in this Amendment, the Reporting Persons currently do not have any plans or proposals that would result in or relate to any of the transactions or changes listed in Items 4(a) through 4(j) of the Schedule 13D."

Industry Context

This filing is a routine ownership disclosure for a publicly traded biotechnology company. While it doesn't directly address industry trends, the CEO's continued significant stake and long-term estate planning suggest stability in leadership for Adagene, which operates in the competitive and capital-intensive pharmaceutical and biotechnology sector.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Related Party Transactions

• Peter Luo and Xiaohong She received shares from Great Han Fortune LP.
• Peter Luo and Xiaohong She transferred shares to HAN 2020 Irrevocable Trust, a family trust established by Peter Luo.
• The Concert Party Agreement involves Peter Luo and other key employees/former employees.

Stakeholder Impact

• Shareholders: Provides transparency on significant ownership changes and the long-term estate planning of the CEO. The shift of shares to an independently managed trust could be viewed positively for governance.
• Management/Employees: The Concert Party Agreement continues to solidify Peter Luo's controlling position, providing clear leadership. The departure of some members from the concert party group reflects broader personnel changes within the company.

Next Steps

• Peter Luo and the Peter Luo-Acting-in-Concert-Group may acquire additional ordinary shares.
• Potential acquisition of shares through outstanding or future share options.
• Potential acquisition of shares through a personal share repurchase plan established by Mr. Luo.

Key Dates

Recommendation

Keywords

Adagene Inc., ADAG, SEC Filing, Schedule 13D, Beneficial Ownership, Peter Luo, HAN 2020 Irrevocable Trust, Estate Planning, Corporate Governance, Share Options, Concert Party Agreement, Biotechnology, Pharmaceuticals